These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25475597)

  • 1. Advances in the evaluation and management of esophageal disease of systemic sclerosis.
    Carlson DA; Hinchcliff M; Pandolfino JE
    Curr Rheumatol Rep; 2015 Jan; 17(1):475. PubMed ID: 25475597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.
    Stern EK; Carlson DA; Falmagne S; Hoffmann AD; Carns M; Pandolfino JE; Hinchcliff M; Brenner DM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 29110377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory Gastroesophageal Reflux Disease and Functional Heartburn.
    Spechler SJ
    Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):343-359. PubMed ID: 32146950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity.
    Raja J; Ng CT; Sujau I; Chin KF; Sockalingam S
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):115-121. PubMed ID: 26843456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
    Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
    Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry.
    Luciano L; Granel B; Bernit E; Harle JR; Baumstarck K; Grimaud JC; Bouvier M; Vitton V
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):63-69. PubMed ID: 27243115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis.
    Zentilin P; Savarino V; Marabotto E; Murdaca G; Sulli A; Pizzorni C; Puppo F; Savarino E
    Semin Arthritis Rheum; 2018 Feb; 47(4):569-574. PubMed ID: 28870413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease.
    Patti MG
    JAMA Surg; 2016 Jan; 151(1):73-8. PubMed ID: 26629969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrointestinal involvement in systemic sclerosis].
    Marie I
    Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal Reflux Disease-Related Disorders of Systemic Sclerosis Based on the Analysis of 66 Patients.
    Matsuda R; Yamamichi N; Shimamoto T; Sumida H; Takahashi Y; Minatsuki C; Kodashima S; Ono S; Niimi K; Tsuji Y; Sakaguchi Y; Saito I; Kataoka Y; Asada-Hirayama I; Kakimoto H; Yakabi S; Takeuchi C; Matsumoto Y; Tamaki Z; Fujishiro M; Asano Y; Sato S; Koike K
    Digestion; 2018; 98(4):201-208. PubMed ID: 30045036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
    de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
    Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.
    Tétreault MP; Kahrilas P
    Curr Rheumatol Rep; 2019 Jul; 21(8):42. PubMed ID: 31270707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment.
    Chen J; Brady P
    Gastroenterol Nurs; 2019; 42(1):20-28. PubMed ID: 30688703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Diagnosis of GERD.
    Jeong ID
    Korean J Gastroenterol; 2017 Feb; 69(2):96-101. PubMed ID: 28239077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
    Arif T; Masood Q; Singh J; Hassan I
    BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.